REATA PHARMACEUTICALS INC Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four in USD from Q1 2019 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Reata Pharmaceuticals Inc quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and growth rate from Q1 2019 to Q2 2023.
  • Reata Pharmaceuticals Inc Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending June 30, 2023 was $14.8M.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $14.8M Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $12.2M Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $12M -$1.73M -12.6% Dec 31, 2022 10-K 2023-02-24
Q3 2022 $14M Sep 30, 2022 10-Q 2022-11-08
Q4 2021 $13.7M Dec 31, 2021 10-K 2022-02-28
Q3 2019 $1.18M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $1.18M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $1.18M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.